These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29625856)

  • 1. Characteristics and outcomes of reversed patients admitted to an emergency department for VKA-related intramuscular hematoma.
    Moustafa F; Poujol L; Vincent N; Saint-Denis J; Dublanchet N; Breuil N; Heuser S; Lebreton A; Dutheil F; Schmidt J
    Am J Emerg Med; 2018 Jul; 36(7):1257-1261. PubMed ID: 29625856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative treatment of large rectus sheath hematoma in patients undergoing anticoagulant therapy.
    Berná JD; Zuazu I; Madrigal M; García-Medina V; Fernández C; Guirado F
    Abdom Imaging; 2000; 25(3):230-4. PubMed ID: 10823439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rectus sheath hematoma: a rarely diagnosed complication of anticoagulation therapy].
    Elikowski W; Małek M; Klich A; Wróblewski D; Gizło J
    Pol Merkur Lekarski; 2012 May; 32(191):309-12. PubMed ID: 22779338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment With Prothrombin Complex Concentrate to Enable Emergency Lumbar Puncture in Patients Receiving Vitamin K Antagonists.
    Laible M; Beynon C; Sander P; Purrucker J; Müller OJ; Möhlenbruch M; Ringleb PA; Rizos T
    Ann Emerg Med; 2016 Sep; 68(3):340-4. PubMed ID: 27085368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates.
    Huttner HB; Schellinger PD; Hartmann M; Köhrmann M; Juettler E; Wikner J; Mueller S; Meyding-Lamade U; Strobl R; Mansmann U; Schwab S; Steiner T
    Stroke; 2006 Jun; 37(6):1465-70. PubMed ID: 16675739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute, major muscular hematoma associated with antithrombotic agents: A multicenter real-world cohort.
    Bouget J; Huet MC; Roy PM; Viglino D; Lacut K; Pavageau L; Oger E
    Thromb Res; 2021 Mar; 199():54-58. PubMed ID: 33429124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate.
    Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S
    Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
    Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
    Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3).
    Abdoellakhan RA; Khorsand N; Van Hest RM; Veeger N; Ter Avest E; Ypma PF; Faber LM; Meijer K
    BMJ Open; 2018 Mar; 8(3):e020764. PubMed ID: 29540424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant-Related Intramuscular Hematomas in an Inpatient Acute Rehabilitation Population: A Case Series.
    Kallas PG; Zalinger M; Sliwa JA; Eskandari MK
    Am J Phys Med Rehabil; 2022 Jan; 101(1):e11-e14. PubMed ID: 34483262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical management and outcome of major bleeding in patients on treatment with vitamin K antagonists.
    Becattini C; Franco L; Masotti L; Nitti C; Cattinelli S; Cappelli R; Manina G; Sbrojavacca R; Pomero F; Agnelli G
    Eur J Intern Med; 2016 Sep; 33():47-54. PubMed ID: 27289494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does IV contrast extravasation on CT in anticoagulant-related rectus sheath and iliopsoas hematoma predict hematoma expansion and patient outcomes?
    Landecy M; Paquette B; Revel L; Behr J; Badet N; Delabrousse E
    Abdom Radiol (NY); 2016 Nov; 41(11):2241-2247. PubMed ID: 27405643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of vitamin K antagonist overcoagulation. A case-control study in unselected patients referred to an emergency department.
    Cadiou G; Varin R; Levesque H; Grassi V; Benichou J; Tiret I; Dieu B; Lecam-Duchez V; Borg JY; Muller JM; Benhamou Y; Marie I
    Thromb Haemost; 2008 Oct; 100(4):685-92. PubMed ID: 18841293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients.
    Karrowni W; Wang TY; Chen AY; Thomas L; Saucedo JF; El Accaoui RN
    Heart; 2015 Feb; 101(4):264-70. PubMed ID: 25336230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization for vitamin-K-antagonist-related bleeding: treatment patterns and outcome.
    Halbritter K; Beyer-Westendorf J; Nowotny J; Pannach S; Kuhlisch E; Schellong SM
    J Thromb Haemost; 2013 Apr; 11(4):651-9. PubMed ID: 23347087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of intraparenchymal hemorrhage after direct oral anticoagulant or vitamin K antagonist therapy: A systematic review and meta-analysis.
    DiRisio AC; Harary M; Muskens IS; Yunusa I; Gormley WB; Aglio LS; Smith TR; Connors JM; Mekary RA; Broekman MLD
    J Clin Neurosci; 2019 Apr; 62():188-194. PubMed ID: 30472344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute subdural hematoma in patients on oral anticoagulant therapy: management and outcome.
    Won SY; Dubinski D; Bruder M; Cattani A; Seifert V; Konczalla J
    Neurosurg Focus; 2017 Nov; 43(5):E12. PubMed ID: 29088960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vitamin K antagonist overdose induced blindness in an infant: an argument for a therapeutic educational program].
    Bui Quoc E; Bonnet D; Bajolle F
    Arch Pediatr; 2012 Jan; 19(1):22-6. PubMed ID: 22169573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists.
    Kooistra HA; Calf AH; Piersma-Wichers M; Kluin-Nelemans HC; Izaks GJ; Veeger NJ; Meijer K
    JAMA Intern Med; 2016 Aug; 176(8):1176-83. PubMed ID: 27379731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.